1 / 5

High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size 2020 Global Industry Brief Analysis by Top Countries

The global high potency active pharmaceutical ingredients (HPAPIs) market is estimated to reach USD 42.8 billion mark by 2026, growing at a CAGR of 11.2% during the forecast period from 2020 to 2026.

DamonGillespie
Download Presentation

High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size 2020 Global Industry Brief Analysis by Top Countries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adroit Market Research High Potency Active Pharmaceutical High Potency Active Pharmaceutical Ingredients (HPAPI) Market Ingredients (HPAPI) Market by Product Type (Lemon Oil, Orange Oil, Peppermint Oil, Lime Oil, Citronella Oil, Cornmint Oil, Spearmint Oil, Cloveleaf Oil, Geranium Oil, Jasmine Oil, Eucalyptus Oil, Rosemary Oil, Lavender Oil, Tea Tree Oil, and Others), Method of Extraction (Distillation, Cold Press Extraction, Carbon Dioxide Extraction, Solvent Extraction, and Others), End Use (Food & Beverages, Aromatherapy, Cosmetics & Toiletries, Healthcare, Homecare, and Others) and by Region, Global Forecasts 2018 to 2025 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research High Potency Active Pharmaceutical Ingredients (HPAPI) Market High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Size and Share 2025 and Share 2025 • The global high potency active pharmaceutical ingredients (HAPAIs) market is anticipated to reach a value of USD 42.8 billion by 2026, growing at a CAGR of 11.2% during the forecast period from 2020 to 2026. Increasing demand for fast-acting drugs and thereby its manufacturers is deemed as the direct driver of the global high potency APIs market. Furthermore, increasing demand for cancer drugs, antibody drug conjugates and growing focus of pharmaceutical companies to expand their base with innovative drugs along with the emerging trend of precision medicine drive the HPAPIs market. • Additionally, supportive government regulations for establishment of new companies and manufacturing units in both developed and developing economies, conducive environment for research and development of new molecules will also drive the market growth. Conversely, though excessively large capital investments may be a challenge for companies, advent of contract manufacturing activities will offset this challenge. • This report studies the global HPAPIs market in terms of products, manufacturing base, drug type and disease areas. Geographical demarcation of the global market into 5 major regions is also considered in this study along with respective top countries in each region. Based on types, the global HPAPIs market is segmented into synthetic and biotech HPAPIs; of these, owing to the large set of manufacturers scattered worldwide, the market for synthetic HPAPIs is the largest in the base year 2019. Between innovative and biosimilar/synthetic drugs, the market share of innovative drugs is high despite their low volume. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research High Potency Active Pharmaceutical Ingredients (HPAPI) Market High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Size and Share 2025 and Share 2025 • Based on manufacturer, the market is categorized into captive HPAPI and merchant HPAPI. Between these two segments, captive HPAPI segment takes the larger market share. The dominance of this segment is attributed to high preference of innovative molecule manufacturing company to retain their in-house manufacturing facilities. However, this trend off late is witnessing a radical yet gradual change and therefore rendering rapidly increasing CAGR of merchant HPAPIs. Considering the application across different disease areas, the demand fir HPAPIs for cancer drugs is currently the highest and the same trend is anticipated to continue throughout the forecast period. High prevalence of cancer and continuous research and development occurring in this space towards introducing novel cancer drugs is a main attribute of this segment. • Adroit Market Research report on global HPAPIs market gives a holistic view of the market from 2016 to 2026, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2016 to 2018, with the base year of estimation as 2019 and forecast from 2020 to 2026. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global HPAPIs market have been studied in detail. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research High Potency Active Pharmaceutical Ingredients (HPAPI) Market High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Size and Share 2025 and Share 2025 • Key Segments of the Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market • Product Overview, 2016-2026 (USD Million) • Synthetic • Biotech • Manufacturing Overview, 2016-2026 (USD Million) • Captive • Merchant • Drug Type Overview, 2016-2026 (USD Million) • Innovative • Biosimilars/Generic • Disease Area Overview, 2016-2026 (USD Million) • Cardiovascular • Oncology • Diabetes • Central Nervous System • Inflammation/Autoimmune • Pain • Others +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and many more. Contact Us US Headquarters Phone: +1 972-362 -8199 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related